Skip to main content
SR biotek Inc. logo

SR biotek Inc. — Investor Relations & Filings

Ticker · 270210 ISIN · KR7270210008 KO Manufacturing
Open in API
Filings indexed 190 across all filing types
Latest filing 2020-06-15 Regulatory Filings
Country KR South Korea
Listing KO 270210

About SR biotek Inc.

http://srbiotek.com/

SR biotek Inc. is a biotechnology and cosmeceutical company specializing in the research, development, and manufacturing of innovative skincare products. The company offers comprehensive turnkey OEM/ODM solutions to its partners, covering product development, quality control, and manufacturing. A core strength lies in the development of novel ingredients, highlighted by its proprietary bio-material, RAPHITOX, which utilizes a micro-needle shaped structure. In addition to its manufacturing services, SR biotek also develops its own branded skincare lines.

Recent filings

Filing Released Lang Actions
지정자문인선임계약의해지
Regulatory Filings Classification · 95% confidence The document is a short, formal announcement regarding the termination of a designated advisor contract (지정자문인 선임계약의 해지) for the company SR Biotech. It provides specific dates and reasons for the contract termination. Since it is a regulatory announcement regarding a corporate administrative change that does not fit into specific categories like M&A, Board changes, or financial reports, it falls under the general regulatory filing category.
2020-06-15 Korean
지정자문인선임계약의체결
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the appointment of a new designated advisor (Daishin Securities) following the termination of a previous contract. It does not contain full financial statements or comprehensive reports, but rather serves as a regulatory notification of a corporate administrative change. As it does not fit into specific categories like M&A, Board changes, or Share issues, it falls under the general regulatory filing category.
2020-06-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status and changes in ownership (acquisitions and disposals) by Core Asset Management in SR Biotech. This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) as it tracks significant ownership thresholds.
2020-06-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. It details the changes in share ownership (specifically '장내매도' or market sales) by a major shareholder, Core Asset Management Co., Ltd., in the company SR Biotech. This type of filing is a standard regulatory disclosure for major shareholders to report changes in their holdings, which falls under the 'Major Shareholding Notification' category.
2020-06-10 Korean
기타주요경영사항(자율공시)(상환전환우선주의 보통주 전환)
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing from a Korean company (SR Biotech) regarding the conversion of Redeemable Convertible Preference Shares (RCPS) into common stock. This involves a change in the company's capital structure and share count. According to the provided definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate category for announcements regarding new share issues or capital changes resulting from conversions.
2020-04-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory disclosure required by the Financial Supervisory Service (FSS) in South Korea when a major shareholder or executive changes their stake in a company. It details the specific shareholding changes of (주)비투링크 in (주)에스알바이오텍. This falls under the category of 'Director's Dealing' (DIRS) as it reports insider/major shareholder transactions.
2020-04-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.